Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2026-05-26 @ 5:46 PM
Study NCT ID:
NCT00003669
Status:
COMPLETED
Last Update Posted:
2012-06-07
First Post:
1999-11-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer
Sponsor:
Eli Lilly and Company
Organization: